NASDAQ:CORT

Corcept Therapeutics Stock News

etoro logo Buy CORT
*Your capital is at risk
$72.65
+1.45 (+2.04%)
At Close: Jun 03, 2026
CORT earnings call for the period ending December 31, 2019.
Corcept Therapeutics, Inc. (NASDAQ:CORT) Q4 2019 Earnings Conference Call February 20, 2020, 17:00 ET Company Participants Gary Robb - CFO & Secretary Josep
Corcept (CORT) delivered earnings and revenue surprises of 0.00% and -0.01%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Corcept (CORT) delivered earnings and revenue surprises of 0.00% and -0.01%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Corcept: 4Q Earnings Snapshot

10:06pm, Thursday, 20'th Feb 2020
MENLO PARK, Calif. (AP) _ Corcept Therapeutics Inc. (CORT) on Thursday reported fourth-quarter profit of $29.4 million. On a per-share basis, the Menlo Park, California-based company said it had net i

Corcept: 4Q Earnings Snapshot

10:05pm, Thursday, 20'th Feb 2020
MENLO PARK, Calif. (AP) _ Corcept Therapeutics Inc. (CORT) on Thursday reported fourth-quarter profit of $29.4 million. On a per-share basis, the Menlo Park, California-based company said it had net i
MENLO PARK, Calif., Feb. 20, 2020 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE